Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta‐analysis

Cited by (1,000)

Items 501–600 of 1,000

1. Retrospective Analysis of the Effectiveness and Tolerability of Long-Acting Paliperidone Palmitate Antipsychotic in Adolescent First-Episode Schizophrenia Patients
   Daniela Petrić, Valentino Rački, Nadija Gačo, Ana Kaštelan, Mirjana Graovac · 2019 · Journal of Child and Adolescent Psychopharmacology
2. Associations of the Built Environment With Physical Activity and Sedentary Time in Ugandan Outpatients With Mental Health Problems
   Davy Vancampfort, Brendon Stubbs, James F. Sallis, Justine Nabanoba, David Basangwa, Adewale Lukman Oyeyemi, Sandra S. Kasoma, Marc D. Binder, Inez Myin‐Germeys, James Mugisha · 2019 · Journal of Physical Activity and Health
3. Association Between Circulating Lipids and Future Weight Gain in Individuals With an At-Risk Mental State and in First-Episode Psychosis
   Santosh Lamichhane, Alex M. Dickens, Partho Sen, Heikki Laurikainen, Faith Borgan, Jaana Suvisaari, Tuulia Hyötyläinen, Oliver David Howes, Jarmo A. Hietala, Matej Orešič · 2020 · Schizophrenia Bulletin
4. Prevalence of metabolic syndrome among patients with depressive disorder admitted to a psychiatric inpatient unit: A comparison with healthy controls
   Sandeep Grover, Naresh Nebhinani, Subho Chakrabarti, Ajit Avasthi · 2017 · Asian Journal of Psychiatry
5. A phenome-wide association and Mendelian Randomisation study of polygenic risk for depression in UK Biobank
   Xueyi Shen, David M. Howard, Mark J. Adams, Ian J. Deary, Heather Clare Whalley, Andrew Mark McIntosh · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
6. Benefits, Facilitators and Barrier Reductions in Physical Activity Programmes for People with Severe Mental Disorder: A Systematic Review
   Méndez-Aguado, Cristina, Cangas, Adolfo J., Aguilar-Parra, José M., Lirola, María J. · 2023 · Healthcare
7. The pharmacological treatment of schizophrenia: how far have we come?
   Rubio, Jose M., Kane, John M. · 2022 · Psychiatry and Clinical Neurosciences Reports
8. Mortality from respiratory diseases in individuals with severe mental illness: a large-scale systematic review and meta-analysis of pooled and specific diagnoses
   David Laguna-Muñoz, María P. Pata, Ana Jiménez-Peinado, María José Jaén‐Moreno, Cristina Camacho-Rodríguez, Gloria Isabel del Pozo, Eduard Vieta, Christoph Ulrich Correll, Marco Solmi, Javier Caballero‐Villarraso et al. · 2025 · The Lancet Psychiatry
9. GLP-1 agonists: superior for mind and body in antipsychotic-treated patients?
   Kateřina Horská, Jana Kučerová, Silje Skrede · 2022 · Trends in Endocrinology and Metabolism
10. Association of psychiatric disorders with clinical diagnosis of long COVID in US veterans
    Kristen M. Nishimi, Thomas C. Neylan, Daniel Bertenthal, Karen H. Seal, Aoife O’Donovan · 2024 · Psychological Medicine
11. Association of cytokines levels, psychopathology and cognition among CR-TRS patients with metabolic syndrome
    Yeqing Dong, Minghuan Zhu, Yanzhe Li, Nannan Liu, Xinxu Wang, Bing Yang, Shen Li, Zezhi Li · 2024 · Schizophrenia
12. Why are cardiovascular diseases more common among patients with severe mental illness? The potential involvement of electronegative low-density lipoprotein (LDL) L5
    Ömer Akyol, Imtihan Chowdhury, Hafsa Rana Akyol, Kylie Tessier, Hüseyin Vural, Sümeyya Akyol · 2020 · Medical Hypotheses
13. Employers With Metabolic Syndrome and Increased Depression/Anxiety Severity Profit Most From Structured Exercise Intervention for Work Ability and Quality of Life.
    Sven Haufe, Kai G. Kahl, Arno Kerling, Gudrun Protte, Pauline Bayerle, Hedwig Theda Stenner, Simone Rolff, Thorben Sundermeier, Julian Eigendorf, Momme Kück et al. · 2020 · Frontiers in Psychiatry
14. Assessing dietary and lifestyle risk behaviours and their associations with disease comorbidities among patients with depression: A case-control study from Bahrain
    Haitham Jahrami, Zahra Saif, Muntadher AlHaddad, MoezAlIslam E. Faris, Laila Hammad, Batool Ali · 2020 · Heliyon
15. Association between high BMI and high homocysteine levels in Chinese patients with bipolar disorder
    Li Mu, Feng Yu, Jiejing Xia, Xiaoe Lang, Anam Haque, Hanjing Emily Wu, Xiangyang Zhang · 2021 · Journal of Affective Disorders
16. Elevated risk of liver steatosis in first-episode psychosis patients: Results from a 3-year prospective study
    S. Galiano Rus, Víctor Ortiz‐García de la Foz, M. Arias, Paula Iruzubieta, Marcos Gómez‐Revuelta, María Juncal‐Ruíz, Javier Crespo, Benedicto Crespo‐Facorro, Javier Vázquez-Bourgón · 2022 · Schizophrenia Research
17. Are the antidepressant effects of insulin-sensitizing medications related to improvements in metabolic markers?
    Temi Toba-Oluboka, Kristýna Vochosková, Tomáš Hájek · 2022 · Translational Psychiatry
18. Artesunate prevents rats from the clozapine-induced hepatic steatosis and elevation in plasma triglycerides
    Yanmei Li, Ruibing Su, Shuqin Xu, Qingjun Huang, Haiyun Xu · 2017 · Neuropsychiatric Disease and Treatment
19. Revisiting the International Physical Activity Questionnaire (IPAQ): Assessing sitting time among individuals with schizophrenia
    Markus J. Duncan, Kelly P. Arbour‐Nicitopoulos, Mehala Subramaniapillai, Gary J. Remington, Guy Faulkner · 2018 · Psychiatry Research
20. Resistance training in patients with schizophrenia: Concept and proof of principle trial
    Isabel Maurus, C. Mantel, Katriona Keller-Varady, Andrea Schmitt, Moritz Lembeck, Astrid Röh, Irina Papazova, Peter Falkai, T. Schneider-Axmann, Alkomiet Hasan et al. · 2019 · Journal of Psychiatric Research
21. A Review of Switching Strategies for Patients with Schizophrenia Comorbid with Metabolic Syndrome or Metabolic Abnormalities
    Xuemei Liao, Hui Ye, Tianmei Si · 2021 · Neuropsychiatric Disease and Treatment
22. Influence of antipsychotics on metabolic syndrome risk in patients with schizophrenia
    Aleksandra Koricanac, Aleksandra Tomic Lucic, Mirjana Veselinović, Danijela Bazic Sretenovic, Gorica Bucic, Anja Azanjac, Olivera Radmanović, Mirjana Matovic, Marijana Stanojević-Pirković, Aleksandra Jurišić-Škevin et al. · 2022 · Frontiers in Psychiatry
23. Schizophrenia and the COVID-19 pandemic: A narrative review from the biomedical perspective
    Krzysztof Kowalski, Błażej Misiak · 2023 · Revista de Psiquiatría y Salud Mental
24. The impact of body mass index on the clinical features of bipolar disorder: A STEP‐BD study
    Bashkim Kadriu, Zhi‐De Deng, Christoph Kraus, Jenessa N. Johnston, Adam Fijtman, Ioline D. Henter, Siegfried F. Kasper, Carlos A. Zarate · 2023 · Bipolar Disorders
25. The effect of a computerized best practice alert system in an outpatient setting on metabolic monitoring in patients on second‐generation antipsychotics
    Sydnee Cohen, Jolene R. Bostwick, Vincent D. Marshall, Kathleen L. Kruse, Gregory W. Dalack, Paresh D. Patel · 2020 · Journal of Clinical Pharmacy and Therapeutics
26. An implementation framework and a feasibility evaluation of a clinical decision support system for diabetes management in secondary mental healthcare using CogStack
    Dipen Patel, Yamiko Joseph Msosa, Tao Wang, Omar G. Mustafa, Siobhan Gee, Julie Williams, Angus Roberts, Richard Dobson, Fiona Gaughran · 2022 · BMC Medical Informatics and Decision Making
27. Effects of metabolic syndrome and obesity on suicidality in individuals with bipolar disorder
    Christoph Stenzel, Nina Dalkner, ­Human‐Friedrich Unterrainer, Armin Birner, Susanne Bengesser, Frederike T. Fellendorf, Andréas Fink, Eva Fleischmann, Melanie Lenger, Alexander Maget et al. · 2022 · Journal of Affective Disorders
28. The Effects of Use of Long-Term Second-Generation Antipsychotics on Liver and Kidney Function: A Prospective Study
    Evangelia Papatriantafyllou, Dimitris Efthymiou, Maria Markopoulou, Efthymia-Maria Sakellariou, Εmilia Vassilopoulou · 2022 · Diseases
29. The Gender-Specific Association of DRD2 Polymorphism with Metabolic Syndrome in Patients with Schizophrenia
    Diana Z. Paderina, Anastasiia S. Boiko, Ivan V. Pozhidaev, Irina A. Mednova, Гончарова Анастасия Александровна, А. В. Бочарова, Olga Y. Fedorenko, Elena G. Kornetova, Arkadiy V. Semke, Nikolay A. Bokhan et al. · 2022 · Genes
30. Prospective associations of exercise and depressive symptoms in older adults: the role of apolipoprotein E4
    Po‐Wen Ku, Andrew Steptoe, Li‐Jung Chen · 2017 · Quality of Life Research
31. Sedentary behaviour patterns in outpatients with severe mental illness: a cross-sectional study using objective and self-reported methods. The PsychiActive project
    Javier Bueno‐Antequera, Miguel Ángel Oviedo‐Caro, Diego Munguía‐Izquierdo · 2017 · Psychiatry Research
32. Clinical Physical Therapy
    Toshiaki Suzuki · 2017 · InTech eBooks
33. Protocol for a randomised controlled trial of interventions to promote adoption and maintenance of physical activity in adults with mental illness
    Justin James Chapman, Shuichi Suetani, Dan J. Siskind, Steve R Kisely, Michael J Breakspear, Jacqueline H. Byrne, Sue Patterson · 2018 · BMJ Open
34. The beliefs of non‐psychiatric doctors about the causes, treatments, and prognosis of schizophrenia
    Lorenza Magliano, Giulia Citarelli, John Read · 2019 · Psychology and Psychotherapy Theory Research and Practice
35. The prevalence, risk factors and clinical correlates of diabetes mellitus in Chinese patients with schizophrenia
    Lijuan Huo, Guangya Zhang, Xiangdong Du, Qiaqiufang Jia, Zheng-Kang Qian, Dachun Chen, Meihong Xiu, Fengchun Wu, Jair C. Soares, Xingbing Huang et al. · 2020 · Schizophrenia Research
36. Safety and Effectiveness of Lurasidone in Patients with Schizophrenia: A 12-Week, Open-Label Extension Study
    Masaomi Iyo, Jun Ishigooka, Masatoshi Nakamura, Reiko Sakaguchi, Keisuke Okamoto, Yongcai Mao, Joyce Tsai, Alison Fitzgerald, Kentaro Takai, Teruhiko Higuchi · 2021 · Neuropsychiatric Disease and Treatment
37. Cardiovascular risk factors and metabolic syndrome in patients treated with long-acting injectables antipsychotics: a retrospective study
    Vera De Carlo, Benedetta Maria Grancini, Niccolò Cassina, Lorenzo Casati, Eleonora Piccoli, Matteo E.M. Vismara, Dario Gobbo, Raffaella Zanaschi, Susanna Lupo, Silvia Olivieri et al. · 2022 · International Clinical Psychopharmacology
38. Major Malformation Risk, Pregnancy Outcomes, and Neurodevelopmental Outcomes Associated With Metformin Use During Pregnancy
    Chittaranjan Andrade · 2016 · The Journal of Clinical Psychiatry
39. High risk of metabolic syndrome among black South African women with severe mental illness
    Shamima Saloojee, Jonathan Kenneth Burns, Ayesha Ahmed Motala · 2017 · South African Journal of Psychiatry
40. Editorial: Brain-Metabolic Crossroads in Severe Mental Disorders—Focus on Metabolic Syndrome
    Salvi, Virginio, Hajek, Tomas · 2019 · Frontiers in Psychiatry
41. Atypical Depression Is Associated With a Distinct Clinical, Neurobiological, Treatment Response and Polygenic Risk Profile
    Mirim Shin, Jacob J. Crouse, Tian Lin, Enda M. Byrne, Brittany L. Mitchell, Penelope A. Lind, Richard Parker, Sarah McKenna, Emiliana Tonini, Joanne Sarah Carpenter et al. · 2026 · Biological Psychiatry
42. Identifying determinants of diabetes risk and outcomes for people with severe mental illness: a mixed-methods study
    Jennie Lister, Lu Han, Sue Bellass, Jo Taylor, Sarah Louise Alderson, Tim Doran, Simon M. Gilbody, Catherine Elizabeth Hewitt, Richard I. G. Holt, Rowena Jacobs et al. · 2021 · Health Services and Delivery Research
43. Prevalence of Metabolic Syndrome and Insulin Resistance in a Sample of Adult ADHD Outpatients
    Giulia di Girolamo, I.F. Bracco, Alberto Portigliatti Pomeri, Soraya Puglisi, Francesco Oliva · 2022 · Frontiers in Psychiatry
44. Transcriptomic Analysis of the Amygdala in Subjects with Schizophrenia, Bipolar Disorder and Major Depressive Disorder Reveals Differentially Altered Metabolic Pathways
    Xiaolu Zhang, Jake Valeri, Mahmoud Ali Eladawi, Barbara Gisabella, Michael R. Garrett, Eric J. Vallender, Robert Erne McCullumsmith, Harry Pantazopoulos, Sinead Marie O'Donovan · 2024 · Schizophrenia Bulletin
45. Comparative analysis of gut microbiome-derived short-chain fatty acids in patients with severe mental disorder: Insights from schizophrenia and bipolar disorder
    Gonzalo Paniagua, Manuel Couce-Sánchez, Leticia González-Blanco, Carlos Sabater, Ainoa García-Fernández, Julia Rodríguez-Revuelta, Pilar Alejandra Sáiz, Julio Bobes, Abelardo Margollés, María Paz García‐Portilla · 2025 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
46. Self concepts, health locus of control and cognitive functioning associated with health-promoting lifestyles in schizophrenia
    Shu Ping Chuang, Jo Yung‐Wei Wu, Chien Shu Wang, Chia Hsuan Liu, Li Hsiang Pan · 2016 · Comprehensive Psychiatry
47. Barriers, attitudes, confidence, and knowledge of nurses regarding metabolic health screening and intervention in people with mental illness: a pilot study from Uganda
    Davy Vancampfort, Andrew Watkins, Philip B. Ward, Michel Probst, Marc D. Binder, Tine Van Damme, James Mugisha · 2019 · African Health Sciences
48. Focus on Brain Health to Improve Care, Treatment, and Rehabilitation in Forensic Psychiatry
    Peter Andiné, Henrik Bergman · 2019 · Frontiers in Psychiatry
49. The role of physical activity in the association between multimorbidity and depressive symptoms: Data from 60,202 adults from the Brazilian National Health Survey
    Aluísio Andrade-Lima, André O. Werneck, Célia Landmann Szwarcwald, Felipe Barreto Schuch, Brendon Stubbs, Afrânio de Andrade Bastos, Danilo Rodrigues Pereira da Silva · 2020 · Journal of Psychosomatic Research
50. Lurasidone and risk for metabolic syndrome: results from short- and long-term clinical studies in patients with schizophrenia
    Michael Tocco, John W. Newcomer, Yongcai Mao, Andrei Pikalov, Antony D Loebel · 2020 · CNS Spectrums
51. Proinflammatory biomarkers are associated with prediabetes in patients with schizophrenia
    Marco Møller, Simon Fredholm, Mathias Ebbesen Jensen, Gitta Wörtwein, Julie Rask Larsen, Tina Vilsbøll, Niels Ødum, Anders Fink‐Jensen · 2020 · CNS Spectrums
52. The association of medical resource utilization with physical morbidity and premature mortality among patients with schizophrenia: An historical prospective population cohort study
    Ido Lurie, Gal Shoval, Moshe Hoshen, Ran D. Balicer, Mark Weiser, Abraham Weizman, Amir Krivoy · 2021 · Schizophrenia Research
53. Physical Health Impairment and Exercise as Medicine in Severe Mental Disorders: A Narrative Review
    Mathias Forsberg Brobakken, Mona Nygård, Eivind Wang · 2022 · Sports Medicine - Open
54. Age of Onset Moderates the Association between Total Antioxidant Capacity and Cognitive Deficits in Patients with Drug-Naïve Schizophrenia
    Jiaxin Li, Deyang Li, Junru Guo, Dongmei Wang, Xiangyang Zhang · 2023 · Antioxidants
55. Exploring the Use of Digital Interventions by People with Severe Mental Illness to Support Their Physical Health: A Mixed Methods Study
    Cathy Gillis, Julie Williams, George Gillett, Ray McGrath, Karen Ang, Ioannis Bakolis, Jorge Arias de la Torre, Gracie Tredget, Fiona Gaughran, Sean Cross et al. · 2024 · Issues in Mental Health Nursing
56. Familial liability to psychosis is a risk factor for multimorbidity in people with psychotic disorders and their unaffected siblings
    Md. Atiqul Islam, Maha Khan, Piotr J. Quee, Harold Snieder, Edwin R. van den Heuvel, Richard Bruggeman, Behrooz Z. Alizadeh, GROUP Investigators, Nico J.M. van Beveren, Wiepke Cahn et al. · 2017 · European Psychiatry
57. Melatonin for Atypical Antipsychotic-Induced Metabolic Adverse Effects: A Meta-Analysis of Randomized Controlled Trials
    Ashwin Kamath, Zahoor Ahmad Rather · 2018 · BioMed Research International
58. The need to improve detection and treatment of physical pain of homeless people with schizophrenia and bipolar disorders. Results from the French Housing First Study
    Guillaume B. Fond, Aurélie Tinland, Mohamed Boucékine, Vincent Girard, Sandrine Loubière, Laurent Boyer, Pascal Auquier · 2018 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
59. Indicators of deterioration in young adults with serious mental illness: a systematic review protocol
    Lindsay Helen Dewa, Elizabeth V. Cecil, Lynne Eastwood, Ara Wardkes Darzi, Paul P Aylin · 2018 · Systematic Reviews
60. A Therapeutic Educational Program in Oral Health for Persons with Schizophrenia: A Qualitative Feasibility Study
    Audrey Peteuil, Corinne Rat, Sahar Moussa-Badran, Maud Carpentier, Jean‐François Pelletier, Frédéric Denis · 2018 · International Journal of Dentistry
61. Higher Prevalence of Metabolic Syndrome in Child-adolescent Patients with Bipolar Disorder
    Satyajit Mohite, Hanjing Wu, Shiva Sharma, Luca Lavagnino, Cristian Zeni, Terrence T. Currie, Jair C. Soares, Teresa A. Pigott · 2020 · Clinical Psychopharmacology and Neuroscience
62. What to Do About Missed Doses? A Retrospective Study of Olanzapine in the Elderly
    Tao Xiao, Zhanzhang Wang, Guanlie Li, Shanqing Huang, Xiuqing Zhu, Shujing Liu, Xiaolin Li, Jinqing Hu, Dewei Shang, Yuguan Wen · 2021 · Drug Design Development and Therapy
63. Mental health in the Pacific: Urgency and opportunity
    Suhailah Ali, Owain David Williams, Odille Chang, Rahul R Shidhaye, Ernest M Hunter, Fiona Charlson · 2020 · Asia Pacific Viewpoint
64. The use of physical exercise in forensic psychiatric care in Sweden: a nationwide survey
    Henrik Bergman, Thomas Nilsson, Peter Andiné, Alessio Degl’Innocenti, Roland Thomeé, Annelie Gutke · 2021 · Journal of Mental Health
65. Increased Global-Brain Functional Connectivity Is Associated with Dyslipidemia and Cognitive Impairment in First-Episode, Drug-Naive Patients with Bipolar Disorder
    Pan Pan, Yan Qiu, Ziwei Teng, Sujuan Li, Jing Huang, Hui Xiang, Hui Tang, Jindong Chen, Chujun Wu, Kun Jin et al. · 2021 · Neural Plasticity
66. Navigating the Minefield: Managing Refusal of Medical Care in Older Adults with Chronic Symptoms of Mental Illness
    Cathal O’Cionnaith, Anne P. F. Wand, Carmelle Peisah · 2021 · Clinical Interventions in Aging
67. Multimorbidity clusters among people with serious mental illness: a representative primary and secondary data linkage cohort study
    Ruimin Ma, Eugenia Romano, Mark Ashworth, Mohammad E. Yadegarfar, Alex Dregan, Amy Ronaldson, Claire de Oliveira, Rowena Jacobs, Robert J. Stewart, Brendon Stubbs · 2022 · Psychological Medicine
68. 3-year incidence and predictors of metabolic syndrome in schizophrenia in the national FACE-SZ cohort
    Ophélia Godin, Baptiste Pignon, Andreı̈ Szöke, Laurent Boyer, Bruno Aouizerate, Benoît Schorr, M. André, Delphine Capdevielle, Isabelle Chéreau, Nathalie Coulon et al. · 2022 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
69. Metabolic profile in first episode drug naïve patients with psychosis and its relation to cognitive functions and social cognition: a case control study
    Samir El Sayed, Sarah Gomaa, Alaa Alhazmi, Ibrahem ElKalla, Dalia Khalil · 2023 · Scientific Reports
70. Associations Between General and Specific Mental Health Conditions in Young Adulthood and Cardiometabolic Complications in Middle Adulthood: A 40-Year Longitudinal Familial Coaggregation Study of 672,823 Swedish Individuals
    Cen Chen, Zheng Chang, Ralf Kuja‐Halkola, Brian Matthew D'Onofrio, Henrik Larsson, Pontus Andell, Paul Lichtenstein, Erik Pettersson · 2024 · American Journal of Psychiatry
71. Monitoring of somatic parameters at outpatient departments for mood and anxiety disorders
    Mirjam Simoons, Hans Mulder, Bennard Doornbos, Robert A. Schoevers, Eric Nico van Roon, Henricus Gerardus Ruhé · 2018 · PLoS ONE
72. Discussion on Patients with Bipolar Disorder and Depressive Episode by Ratio Low Frequency Amplitude Combined with Grey Matter Volume Analysis
    Xiaohong Wang, Na Zhao, Jingjing Shi, Yuhua Wu, Jun Liu, Qiang Feng Xiao, Jian Hu · 2019 · Journal of Medical Systems
73. Improved self‐esteem and activity levels following a 12‐week community activity and healthy lifestyle programme in those with serious mental illness: A feasibility study
    Peter Gallagher, Cailín Boland, Aisling McClenaghan, Felicity Fanning, Elizabeth Lawlor, Mary Clarke · 2020 · Early Intervention in Psychiatry
74. Age at Menarche in Women With Bipolar Disorder: Correlation With Clinical Features and Peripartum Episodes
    Gianluca Rosso, Elena Aragno, Emina Mehanović, Gabriele Di Salvo, Giuseppe Maina · 2020 · Frontiers in Psychiatry
75. Exercise training complementary to specialised early intervention in patients with first-episode psychosis: a feasibility randomised trial
    Julie Midtgaard, Helle Schnor, Eik Dybboe Bjerre, Tobias Jespersen, Nina Jelsøe, Nanna Frølund, Søren Seier, Jacob Willum Rønbøg, Nikolai Baastrup Nordsborg, Bjørn Hylsebeck Ebdrup · 2021 · Pilot and Feasibility Studies
76. Feasibility and Acceptability of Photographic Food Record, Food Diary and Weighed Food Record in People with Serious Mental Illness
    Annabel Sandra Mueller‐Stierlin, Scott B. Teasdale, Uemmueguelsuem Dinc, Sabrina Mörkl, Nicole Prinz, Thomas M Becker, Reinhold Kilian · 2021 · Nutrients
77. Affective Temperament and Glycemic Control – The Psychological Aspect of Obesity and Diabetes Mellitus
    Natalia Lesiewska, Anna Kamińska, Roman Junik, Magdalena Michalewicz, Bartlomiej Myszkowski, Alina Borkowska, Maciej Kazimierz Bieliński · 2021 · Diabetes Metabolic Syndrome and Obesity
78. The Functional Exercise Capacity Is Associated With Global Functioning in People With Bipolar Disorder
    Davy Vancampfort, Pascal A. Sienaert, Sabine Wyckaert, Marc D. Binder, Brendon Stubbs, Justin A. Richards, James Mugisha, Michel Probst · 2016 · The Journal of Nervous and Mental Disease
79. Correlates of metabolic syndrome in patients with depression: A study from north-western India
    Naresh Nebhinani, Praveen Sharma, Navratan Suthar, Vrinda Pareek, Deep Kunwar, Priyanka Purohit, Purvi Purohit · 2020 · Diabetes & Metabolic Syndrome Clinical Research & Reviews
80. Proteomic Analysis of Plasma Markers in Patients Maintained on Antipsychotics: Comparison to Patients Off Antipsychotics and Normal Controls
    Rudolf Engelke, Sami Ouanes, Suhaila Ghuloum, Rifka Chamali, Nancy Kiwan, Hina Sarwath, Frank Schmidt, Karsten Suhre, Hassen A. Al-Amin · 2022 · Frontiers in Psychiatry
81. Home-based Intervention with Semaglutide Treatment of Neuroleptic-Related Prediabetes (HISTORI): protocol describing a prospective, randomised, placebo controlled and double-blinded multicentre trial
    Ashok Ainkaran Ganeshalingam, Nicolai Gundtoft Uhrenholt, Sidse Arnfred, Peter Gæde, Niels Bilenberg, Jan Frystyk · 2024 · BMJ Open
82. Prevalence of metabolic syndrome and its associated factors in first‐treatment drug‐naïve schizophrenia patients: A large‐scale cross‐sectional study
    Suoya Hu, Xuebing Liu, Yanting Zhang, Jun Ma · 2024 · Early Intervention in Psychiatry
83. Interventions targeting patients with co-occuring severe mental illness and substance use (dual diagnosis) in general practice settings – a scoping review of the literature
    Katrine Tranberg Jensen, Bawan Colnadar, Maria Haahr Nielsen, Carsten Rygaard Hjorthøj, Anne Møller · 2024 · BMC Family Practice
84. Real‐world comprehensive care of people living with schizophrenia: recommendations across different settings and clinical stages
    P. Fusar-Poli, T. Pillinger, R. McCutcheon, Thara Rangaswamy, Laila Asmal, Swaran P. Singh, Dominic Oliver, R. Stefanelli, Nicolas A. Crossley, A. Gadelha et al. · 2026 · World Psychiatry
85. Long-Term Assessment of Lurasidone in Schizophrenia: Post Hoc Analysis of a 12-Month, Double Blind, Active-Controlled Trial and 6-Month Open-Label Extension Study
    Preeya J. Patel, Christian Weidenfeller, Andrew P. Jones, Jens Nilsson, Jay Hsu · 2020 · Neurology and Therapy
86. Hepatic steatosis in patients with schizophrenia: a clinical cross-sectional study
    Anna Sofie Kaestel Aarøe, Katrine Odgaard Maeng, Ragnhild Leifsdottir Jacobsen, Svend Eggert Jensen, Claus Graff, Christoffer Polcwiartek, Esben Bolvig Mark, Anja Borgen Dalsgaard, C. Tranekær Hostrup, Pernille Veiss‐Pedersen et al. · 2021 · Nordic Journal of Psychiatry
87. Childhood immuno-metabolic markers and risk of depression and psychosis in adulthood: A prospective birth cohort study
    Nicholas A Donnelly, Benjamin Ian Perry, Hannah J Jones, Golam Mohammed Khandaker · 2022 · Psychoneuroendocrinology
88. Effects of Physical Exercise on Executive Function in Adults with Depression: A Systematic Review and Meta-Analysis Protocol
    Falonn Contreras-Osorio, Rodrigo Ramírez‐Campillo, Enrique Cerda-Vega, Rodrigo Campos-Jara, Cristian Martínez‐Salazar, Rafael E. Reigal, Verónica Morales‐Sánchez, Sergio Araya-Sierralta, Christian Campos‐Jara · 2022 · Sustainability
89. Serum cytokine variations among inpatients with major depression, bipolar disorder, and schizophrenia versus healthy controls: a prospective ‘true-to-life’ study
    Antônio Augusto Schmitt Júnior, Lucas Primo de Carvalho Alves, Barbara Larissa Padilha, Neusa Sica da Rocha · 2023 · Therapeutic Advances in Psychopharmacology
90. Exploring the Relationship between Mood Disorders and Coexisting Health Conditions: The Focus on Nutraceuticals
    Agnieszka Mechlińska, Mariusz Stanisław Wiglusz, Jakub Słupski, Adam Włodarczyk, Wiesław Jerzy Cubała · 2023 · Brain Sciences
91. The risk of stroke and post-stroke mortality in people with schizophrenia: A systematic review and meta-analysis study
    Ryan Sai Ting Chu, Ryan Chi Hin Chong, Don Ho Hin Chang, Alice Lok Shan Leung, Joe Kwun Nam Chan, Corine Sau Man Wong, Wing Chung Chang · 2024 · Psychiatry Research
92. Metabolic syndrome and its relation to antipsychotic polypharmacy in schizophrenia, schizoaffective and bipolar disorders
    Karim Abdel Aziz, Hind Mohd Ahmed, Émmanuel Stip, Dina Aly El‐Gabry · 2024 · International Clinical Psychopharmacology
93. Olanzapine Induces Adipogenesis and Glucose Uptake by Activating Glycolysis and Synergizing with the PI3K-AKT Pathway
    Shen Li, Yun Fu, Wanyao Wang, Jiali Qiu, Yepei Huang, Xuemin Li, Ke Yang, Xiawen Yu, Yanyan Ma, Yuan Zhang et al. · 2024 · Current Neuropharmacology
94. Improving metabolic monitoring rate for young people aged 35 and younger taking antipsychotic medications to treat a psychosis: A literature review
    Gin‐Liang Chee, Dianne Wynaden, Karen Heslop · 2017 · Archives of Psychiatric Nursing
95. Long-Term Evolution of Metabolic Status in Patients with Schizophrenia Stably Maintained on Second-Generation Antipsychotics
    Seong Hoon Jeong, Nam Young Lee, Se Hyun Kim, In Won Chung, Tak Youn, Ung Gu Kang, Yong Min Ahn, Han Young You, Yong Sik Kim · 2018 · Psychiatry Investigation
96. The schizophrenia oral health profile: Development and feasibility
    Frédéric Denis, Corinne Rat, Reynaud Matthieu, Francesca Siu-Paredes, Stéphanie Tubert‐Jeannin, Nathalie Rude · 2018 · Translational Neuroscience
97. Role of Integrated and Multidisciplinary Approach in Combating Metabolic Syndrome in Patients with Severe Mental Illness
    Pooja Patnaik Kuppili, Naresh Nebhinani · 2019 · Indian Journal of Psychological Medicine
98. Receipt of Promotional Payments at the Individual and Physician Network Level Associated with Higher Branded Antipsychotic Prescribing Rates
    Simon Hollands · 2019 · Administration and Policy in Mental Health and Mental Health Services Research
99. Safety attitudes, perceived organizational culture and knowledge of the physiologically deteriorating patient among mental health nurses: Cross‐sectional, correlational study
    Geoffrey L. Dickens, Yenna Salamonson, Lucie Michelle Ramjan, Kelly Steel, Bronwyn Everett · 2019 · International Journal of Mental Health Nursing
100. Validation of the Finnish Health Improvement Profile (HIP) with patients with severe mental illness
     Camilla Werkkala, Maritta Anneli Valimaki, Minna Anttila, Virve Pekurinen, Daniel Thomas Bressington · 2020 · BMC Psychiatry